Jahnke K - Search Results

1

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.

Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L, Korfel A; German Primary Central Nervous System Lymphoma Study Group. Jahnke K, et al. J Neurooncol. 2006 Nov;80(2):159-65. doi: 10.1007/s11060-006-9165-6. Epub 2006 May 13. J Neurooncol. 2006. PMID: 16699873

2

Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature.

Jahnke K, Bechrakis NE, Coupland SE, Schmittel A, Foerster MH, Fischer L, Thiel E, Korfel A. Jahnke K, et al. Graefes Arch Clin Exp Ophthalmol. 2004 Sep;242(9):771-6. doi: 10.1007/s00417-004-0947-2. Graefes Arch Clin Exp Ophthalmol. 2004. PMID: 15349786 Review.

3

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.

Korfel A, Martus P, Nowrousian MR, Hossfeld DK, Kirchen H, Brücher J, Stelljes M, Birkmann J, Peschel C, Pasold R, Fischer L, Jahnke K, Thiel E; German primary central nervous system lymphoma Study Group (G-PCNSL-SG). Korfel A, et al. Among authors: jahnke k. Br J Haematol. 2005 Jan;128(2):177-83. doi: 10.1111/j.1365-2141.2004.05284.x. Br J Haematol. 2005. PMID: 15638851 Free article. Clinical Trial.

4

Low-grade primary central nervous system lymphoma in immunocompetent patients.

Jahnke K, Thiel E, Schilling A, Herrlinger U, Weller M, Coupland SE, Krümpelmann U, Stein H, Korfel A. Jahnke K, et al. Br J Haematol. 2005 Mar;128(5):616-24. doi: 10.1111/j.1365-2141.2004.05361.x. Br J Haematol. 2005. PMID: 15725082 Free article.

5

Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.

Jahnke K, Thiel E, Martus P, Schwartz S, Korfel A. Jahnke K, et al. Ann Hematol. 2006 Jan;85(1):45-50. doi: 10.1007/s00277-005-1096-3. Epub 2005 Aug 13. Ann Hematol. 2006. PMID: 16132909

6

Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.

Jahnke K, Korfel A, Komm J, Bechrakis NE, Stein H, Thiel E, Coupland SE. Jahnke K, et al. Graefes Arch Clin Exp Ophthalmol. 2006 Jun;244(6):663-9. doi: 10.1007/s00417-005-0138-9. Epub 2005 Oct 16. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16228920 Clinical Trial.

7

Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients.

Jahnke K, Schilling A, Heidenreich J, Stein H, Brock M, Thiel E, Korfel A. Jahnke K, et al. AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2446-54. AJNR Am J Neuroradiol. 2005. PMID: 16286384 Free PMC article.

8

International study on low-grade primary central nervous system lymphoma.

Jahnke K, Korfel A, O'Neill BP, Blay JY, Abrey LE, Martus P, Poortmans PM, Shenkier TN, Batchelor TT, Neuwelt EA, Raizer JJ, Schiff D, Pels H, Herrlinger U, Stein H, Thiel E. Jahnke K, et al. Ann Neurol. 2006 May;59(5):755-62. doi: 10.1002/ana.20804. Ann Neurol. 2006. PMID: 16586496

9

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E. Fischer L, et al. Among authors: jahnke k. Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5. Ann Hematol. 2009. PMID: 18679681

10

First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Maza S, Kiewe P, Munz DL, Korfel A, Hamm B, Jahnke K, Thiel E. Maza S, et al. Among authors: jahnke k. Neuro Oncol. 2009 Aug;11(4):423-9. doi: 10.1215/15228517-2008-108. Epub 2008 Dec 5. Neuro Oncol. 2009. PMID: 19060176 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page